Ginkgo Bioworks Holdings, Inc. (DNA)

NYSE: DNA · IEX Real-Time Price · USD
1.100
+0.030 (2.80%)
Mar 27, 2024, 4:00 PM EDT - Market closed
2.80%
Market Cap 2.30B
Revenue (ttm) 251.46M
Net Income (ttm) -892.87M
Shares Out 2.15B
EPS (ttm) -0.46
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 16,093,179
Open 1.070
Previous Close 1.070
Day's Range 1.060 - 1.130
52-Week Range 1.030 - 2.545
Beta 1.42
Analysts Hold
Price Target 2.20 (+100.0%)
Earnings Date May 8, 2024

About DNA

Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming in the United States. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. It serves pharma and biotech, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2008
Employees 1,218
Stock Exchange NYSE
Ticker Symbol DNA
Full Company Profile

Financial Performance

In 2023, DNA's revenue was $251.46 million, a decrease of -47.36% compared to the previous year's $477.71 million. Losses were -$892.87 million, -57.58% less than in 2022.

Financial Statements

Analyst Forecast

According to 5 analysts, the average rating for DNA stock is "Hold." The 12-month stock price forecast is $2.2, which is an increase of 100.00% from the latest price.

Price Target
$2.2
(100.00% upside)
Analyst Consensus: Hold
Stock Forecasts

News

AQUA Cultured Foods Partners with Ginkgo Bioworks to Optimize Alt-Seafood Production

The partners will work to optimize AQUA Cultured Foods' fermentation technology and advance the development and production of AQUA's 100% fish-free products that emulate the look, feel, and taste of f...

1 day ago - PRNewsWire

Imagindairy and Ginkgo Bioworks Collaborate to Develop and Produce Animal-Free Non-Whey Dairy Proteins

Imagindairy and Ginkgo will leverage Ginkgo Protein Expression Services  and Imagindairy's process development and scale-up expertise to economically produce non-whey dairy proteins for the food indus...

2 days ago - PRNewsWire

CDC Traveler-based Genomic Surveillance Program to Expand to Two New US International Airports in Miami and Chicago

The TGS program, a leading example of biosecurity infrastructure, operates at a total of nine US locations and leverages voluntary nasal swabs as well as wastewater sampling from international travele...

Other symbols: XWEL
16 days ago - PRNewsWire

Ginkgo Bioworks Reports Fourth Quarter and Full Year 2023 Financial Results

$251 million of Total revenue in 2023 $139 million in Cell Engineering services revenue, representing 31% growth over 2022 78 new Cell Programs added in 2023, representing 32% growth over 2022 and con...

27 days ago - PRNewsWire

bit.bio Announced as Inaugural Partner of Ginkgo Bioworks' New Technology Network

CAMBRIDGE, England & BOSTON--(BUSINESS WIRE)-- #Celltherapy--bit.bio, the company coding human cells for novel cures, and Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell p...

4 weeks ago - Business Wire

Ginkgo Bioworks Provides Compensation Information Related to Recent Acquisitions

BOSTON , Feb. 28, 2024 /PRNewswire/ -- Today, Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, announced that in connection to its transaction ...

4 weeks ago - PRNewsWire

Ginkgo Bioworks Acquires Proof Diagnostics, Growing Gene Editing Service Offerings for its Customers

BOSTON , Feb. 28, 2024 /PRNewswire/ -- Today, Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, announced the acquisition of Proof Diagnostics, ...

4 weeks ago - PRNewsWire

Ginkgo Bioworks Acquires Patch Biosciences, Expanding Suite of Genetic Medicine Capabilities Available to Customers

BOSTON , Feb. 28, 2024 /PRNewswire/ -- Today, Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, announced the acquisition of Patch Biosciences ,...

4 weeks ago - PRNewsWire

Ginkgo Bioworks Acquires Reverie Labs Platform, Enhancing AI-Driven Drug Discovery Capabilities for Customer Programs

BOSTON , Feb. 28, 2024 /PRNewswire/ -- Today, Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, announced the acquisition of key assets of Rever...

4 weeks ago - PRNewsWire

Ginkgo Technology Network Launches, Providing an Integrated R&D Experience with Capabilities from Over 25 Inaugural Partners

The Ginkgo Technology Network brings together over 25 diverse partners across an array of capabilities including AI, genetic medicines, biologics, and manufacturing Ginkgo plans to integrate the techn...

4 weeks ago - PRNewsWire

Ginkgo Biosecurity Launches Doha-Based Pathogen Monitoring Center, CUBE-D, Establishing Middle East Hub for Global Bioradar, at Qatar Free Zones

The center will be a first of its-kind collection and analysis center for data gathered through Ginkgo's pathogen monitoring network DOHA, Qatar , Feb. 27, 2024 /PRNewswire/ -- Ginkgo Bioworks (NYSE: ...

4 weeks ago - PRNewsWire

Ginkgo Bioworks Announces Participation in the 44th Annual TD Cowen Health Care Conference

BOSTON , Feb. 27, 2024 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced that Co-Founder and CEO, Jason Kelly, i...

4 weeks ago - PRNewsWire

Ginkgo Bioworks Announces Date of Fourth Quarter and Full Year 2023 Results Presentation

Presentation and Q&A session scheduled for post-market on Thursday, February 29, 2024 BOSTON , Feb. 22, 2024 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cel...

4 weeks ago - PRNewsWire

Ginkgo Bioworks and SaponiQx Awarded MCDC Contract to Discover and Manufacture Next-Generation Vaccine Adjuvants Using Generative Molecular Design

BOSTON and LEXINGTON, Mass. , Feb. 15, 2024 /PRNewswire/ -- The Defense Threat Reduction Agency's (DTRA) Joint Science and Technology Office (JSTO) for the Chemical and Biological Defense (CBD) Progra...

Other symbols: AGEN
5 weeks ago - PRNewsWire

House Select Committee Tours Ginkgo Bioworks, Previews Biofab1, Ginkgo's New Integrated Data Generation Facility Set to Launch in 2025

Members of Congress visited Ginkgo's Boston Seaport headquarters to discuss strategies for bolstering U.S. ability to compete in AI applications for biotechnology, as well as unlocking innovations in ...

6 weeks ago - PRNewsWire

Bioluminescent Plants Are Now Even Brighter: Light Bio to Begin Selling Firefly Petunias to Consumers with USDA Approval

KETCHUM, Idaho , Feb. 1, 2024 /PRNewswire/ -- Light Bio, an innovative synthetic biology startup, today announced that it is beginning to sell its groundbreaking bioluminescent petunias in the United ...

7 weeks ago - PRNewsWire

Phytolon and Ginkgo Bioworks Successfully Achieve First Milestone to Produce Vibrant Natural Food Colors via Two Producing Strains

This first milestone has made the full color palette of the yellow-to-purple spectrum accessible for Phytolon's food colors and has further established a unique and cost-efficient offering for the foo...

2 months ago - PRNewsWire

Concentric by Ginkgo and Illumina collaborate to deploy biosurveillance technologies around the world

The companies plan to join forces to set up pathogen monitoring programs utilizing Illumina technology across Concentric's global network  BOSTON and SAN DIEGO , Jan. 15, 2024 /PRNewswire/ -- Concentr...

Other symbols: ILMN
2 months ago - PRNewsWire

Ginkgo Bioworks Provides Business Updates at J.P. Morgan Healthcare Conference

Expects to meet 2023 new program and revenue guidance ranges Ended the year with nearly $950 million in cash and cash equivalents, a strong balance sheet providing multi-year runway as Ginkgo sees ope...

2 months ago - PRNewsWire

Ginkgo Bioworks Announces Inaugural Members of New Biopharma Advisory Board

BOSTON , Jan. 8, 2024 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced the formation of its new Biopharma Advis...

2 months ago - PRNewsWire

Ginkgo Bioworks Completes Program with Biogen to Boost Productivity of Gene Therapy Manufacturing Platform

Collaboration enhanced the productivity of Biogen's AAV production platform to help accelerate efforts to bring novel gene therapies to patients worldwide BOSTON , Jan. 4, 2024 /PRNewswire/ -- Ginkgo ...

2 months ago - PRNewsWire

Ginkgo Bioworks Announces Participation in the 42nd Annual J.P. Morgan Healthcare Conference

BOSTON , Jan. 3, 2024 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced that Co-Founder and CEO, Jason Kelly, is...

3 months ago - PRNewsWire

OneOne Biosciences Partners with Ginkgo Bioworks to Advance its Platform and Nitrogen Fixation Microbial Product

OneOne is a French biotech startup developing a comprehensive suite of agricultural microbial solutions Ginkgo will support OneOne in its agricultural biologicals and synthetic biology R&D Ginkgo will...

3 months ago - PRNewsWire

U.S. Department of Energy Awards Team Led by Ginkgo Bioworks Funding to Develop Algal Crop Protection Solutions

Algae-based biotechnology can be used to drive forward clean energy solutions, such as sustainable aviation fuel, yet scaling algal biotechnologies for such purposes faces major barriers The DOE has a...

3 months ago - PRNewsWire

GreenLab Selects Ginkgo Enzyme Services to Develop Novel Enzyme That Breaks Down 'Forever Chemicals'

GreenLab is creating an enzymatic solution — to be grown and scaled within corn plants — to degrade PFAS, often called "forever chemicals," a major health and environmental concern Ginkgo has been tap...

3 months ago - PRNewsWire